Yingda Securities Co., Ltd.'s inspection opinion on the initial public offering of some restricted shares of Chengdu Olin Biotechnology Co., Ltd. on the listing and circulation of some restricted shares
Announcement of Chengdu Oulin Biotechnology Co., Ltd. on the voluntary disclosure of the quadrivalent influenza virus lytic vaccine (MDCK cells) approval notice for drug clinical trials
Yingda Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Chengdu Olin Biotechnology Co., Ltd.
Yingda Securities Co., Ltd.'s 2023 continuous supervision work site inspection report on Chengdu Olin Biotechnology Co., Ltd.
Investor Relations Activity Record Sheet-20240428
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Chengdu Olin Biotechnology Co., Ltd.
Chengdu Olin Biotechnology Co., Ltd. 2023 Audit Report
Chengdu Oulin Biotechnology Co., Ltd. 2023 Independent Director Debriefing Report (He Shaoping)
Chengdu Olin Biotechnology Co., Ltd. 2023 Social Responsibility Report and ESG (Environmental, Social and Governance) Report
Chengdu Olin Biotechnology Co., Ltd. Internal Control Audit Report
Chengdu Olin Biotechnology Co., Ltd. 2023 Accounting Firm Performance Evaluation Report
Chengdu Oulin Biotechnology Co., Ltd. 2023 Independent Director Debriefing Report (Li Xianchun)
Announcement of Chengdu Oulin Biotechnology Co., Ltd. on the use of some temporarily idle funds raised for cash management
Opinions of Yingda Securities Co., Ltd. on the verification of the use of some idle funds raised by Chengdu Olin Biotechnology Co., Ltd. for cash management
Articles of Association of Chengdu Olin Biotechnology Co., Ltd. (April 2024)
Announcement of Resolutions of the 15th Meeting of the 6th Board of Directors of Chengdu Olin Biotechnology Co., Ltd.
Announcement of Resolutions of the Eighth Meeting of the 6th Board of Supervisors of Chengdu Olin Biotechnology Co., Ltd.
Announcement of Chengdu Olin Biotechnology Co., Ltd. on renewing the employment of an accounting firm
Special Report on the Deposit and Actual Use of Funds Raised in 2023 by Chengdu Oulin Biotechnology Co., Ltd.
Yingda Securities Co., Ltd.'s special inspection opinion on the deposit and use of funds raised by Chengdu Oulin Biotechnology Co., Ltd. in 2023
No Data